OncoImmunology
Volume 10, 2021 - Issue 1
Open access
3,917
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers
Juan-Pablo Cerapioa Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, Francehttps://orcid.org/0000-0002-3032-3180View further author information
, Marion Perriera Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, Francehttps://orcid.org/0000-0001-9234-1811View further author information
, Camille-Charlotte Balançaa Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, FranceView further author information
, Pauline Gravellea Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, France;f Institut Carnot Lymphome CALYM, France;g Centre Hospitalier Universitaire, Toulouse, FranceView further author information
, Fréderic Ponta Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, Francehttps://orcid.org/0000-0002-5493-527XView further author information
, Christel Devauda Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, Francehttps://orcid.org/0000-0003-3511-3219View further author information
, Don-Marc Franchinia Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, France;f Institut Carnot Lymphome CALYM, France;h Institut Claudius Regaud, Toulouse, FranceView further author information
, Virginie Féliua Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, FranceView further author information
, Marie Tosolinia Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, Francehttps://orcid.org/0000-0001-5278-5952View further author information
, Carine Vallea Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, FranceView further author information
, Fréderic Lopeza Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, FranceView further author information
, Anne Quillet-Marya Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, France;f Institut Carnot Lymphome CALYM, FranceView further author information
, Loic Ysebaerta Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, France;f Institut Carnot Lymphome CALYM, France;g Centre Hospitalier Universitaire, Toulouse, FranceView further author information
, Alejandra Martineza Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, FranceView further author information
, Jean Pierre Delorda Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;h Institut Claudius Regaud, Toulouse, FranceView further author information
, Maha Ayyouba Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, FranceView further author information
, Camille Laurenta Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, France;f Institut Carnot Lymphome CALYM, France;g Centre Hospitalier Universitaire, Toulouse, FranceView further author information
& Jean-Jacques Fourniea Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France;b Toulouse University, Toulouse, France;c CNRS UMR 5071, Toulouse, France;d Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France;e Laboratoire d’Excellence ‘TOUCAN-2ʹ, Toulouse, France;f Institut Carnot Lymphome CALYM, FranceCorrespondence[email protected]
https://orcid.org/0000-0001-6542-6908View further author information
show allhttps://orcid.org/0000-0001-6542-6908View further author information
Article: 1939518
|
Received 21 Apr 2021, Accepted 02 Jun 2021, Published online: 18 Sep 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.